Emcure Pharmaceuticals Limited, an Indian firm, that specializes in the development, manufacturing, and worldwide distribution of a diverse range of pharmaceutical products spanning multiple key therapeutic categories, debuted on the Indian stock market today. The company’s stock settled at Rs 1325.05 per share on the BSE, representing an impressive 31.45% premium over the final issue …